GR1001512B - Μέ?οδος παρασκευής συν?έσεων παρατεταμένης απελευ?ερώσεως και οι συν?έσεις οι οποίες λαμβάνονται τοιουτοτρόπως. - Google Patents

Μέ?οδος παρασκευής συν?έσεων παρατεταμένης απελευ?ερώσεως και οι συν?έσεις οι οποίες λαμβάνονται τοιουτοτρόπως.

Info

Publication number
GR1001512B
GR1001512B GR910100330A GR910100330A GR1001512B GR 1001512 B GR1001512 B GR 1001512B GR 910100330 A GR910100330 A GR 910100330A GR 910100330 A GR910100330 A GR 910100330A GR 1001512 B GR1001512 B GR 1001512B
Authority
GR
Greece
Prior art keywords
compositions
preaparation
sustained release
particles
active ingredient
Prior art date
Application number
GR910100330A
Other languages
Greek (el)
English (en)
Other versions
GR910100330A (en
Inventor
Mr Ruiz
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of GR910100330A publication Critical patent/GR910100330A/el
Publication of GR1001512B publication Critical patent/GR1001512B/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Glanulating (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
GR910100330A 1990-08-01 1991-07-30 Μέ?οδος παρασκευής συν?έσεων παρατεταμένης απελευ?ερώσεως και οι συν?έσεις οι οποίες λαμβάνονται τοιουτοτρόπως. GR1001512B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909016885A GB9016885D0 (en) 1990-08-01 1990-08-01 Sustained release pharmaceutical compositions

Publications (2)

Publication Number Publication Date
GR910100330A GR910100330A (en) 1992-08-31
GR1001512B true GR1001512B (el) 1994-02-28

Family

ID=10679993

Family Applications (1)

Application Number Title Priority Date Filing Date
GR910100330A GR1001512B (el) 1990-08-01 1991-07-30 Μέ?οδος παρασκευής συν?έσεων παρατεταμένης απελευ?ερώσεως και οι συν?έσεις οι οποίες λαμβάνονται τοιουτοτρόπως.

Country Status (30)

Country Link
US (1) US5213812A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP2818704B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR920003962A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT396425B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (2) AU649696B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE1004772A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2048270C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH682715A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE4125542A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK175756B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2046083B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI104149B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2665360B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB9016885D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR1001512B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (1) HK33294A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE65124B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN178446B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1251788B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU87982A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MA (1) MA22245A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY107500A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL194637C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO300158B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ238981A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
OA (1) OA09387A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT98497B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE505734C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TN (1) TNSN91067A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA915565B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5569467A (en) * 1993-05-15 1996-10-29 Societe De Conseils De Recherches Et D'applications (S.C.R.A.S.) Process for the preparation of microballs and microballs thus obtained
GB9310030D0 (en) * 1993-05-15 1993-06-30 Scras Dry processed particles and process for the preparation of the same
CA2184242C (en) * 1994-02-28 2000-05-02 Jorg Kreuter Drug targeting system, method for preparing same and its use
US5980945A (en) * 1996-01-16 1999-11-09 Societe De Conseils De Recherches Et D'applications Scientifique S.A. Sustained release drug formulations
DE19604744A1 (de) 1996-02-09 1997-08-14 Henkel Kgaa Technische Di-/Triglyceridgemische
DE19617137C1 (de) * 1996-04-29 1997-02-27 Henkel Kgaa Verwendung von Copolymerestern für die Herstellung von Mikrosphären
EP0930874A2 (en) * 1996-10-09 1999-07-28 Takeda Chemical Industries, Ltd. A method for producing a microparticle
MY118835A (en) * 1997-04-18 2005-01-31 Ipsen Pharma Biotech Sustained release compositions and the process for their preparation
AU3555599A (en) 1998-04-13 1999-11-01 Luminex Corporation Liquid labeling with fluorescent microparticles
HK1041645B (zh) * 1998-12-16 2005-07-29 Aventisub Ii Inc. 生物可降解聚合物包封的5-羟色胺受体拮抗剂及其制备方法
AU5644400A (en) * 1999-09-24 2001-03-29 Rohm And Haas Company Pellet compositions
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
EP1335661B1 (en) 2000-10-27 2009-05-06 Baxter Healthcare S.A. Production of microspheres
US20080026068A1 (en) * 2001-08-16 2008-01-31 Baxter Healthcare S.A. Pulmonary delivery of spherical insulin microparticles
US20030064033A1 (en) * 2001-08-16 2003-04-03 Brown Larry R. Propellant-based microparticle formulations
US20040166077A1 (en) * 2002-12-04 2004-08-26 L'oreal Process for treating keratin materials with aromatic active principles
FR2848113B1 (fr) * 2002-12-04 2005-02-25 Oreal Stabilisation de principes actifs aromatiques par des polymeres aromatiques
US20050142205A1 (en) * 2003-07-18 2005-06-30 Julia Rashba-Step Methods for encapsulating small spherical particles prepared by controlled phase separation
BRPI0412735A (pt) * 2003-07-18 2006-09-26 Baxter Int métodos para a fabricação, uso e composição de partìculas esféricas pequenas preparadas mediante a separação de fase controlada
US20070092452A1 (en) * 2003-07-18 2007-04-26 Julia Rashba-Step Methods for fabrication, uses, compositions of inhalable spherical particles
CA2532874A1 (en) * 2003-07-22 2005-02-03 Baxter International Inc. Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
US20060135277A1 (en) * 2003-09-10 2006-06-22 Marnocha Bendict F Golf club and practice arrangement
FR2865938B1 (fr) * 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
DE602005009954D1 (de) 2004-05-12 2008-11-06 Baxter Int Nukleinsäure-mikrokügelchen, ihre herstellung und abgabe
US8728525B2 (en) * 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
PT1758558E (pt) * 2004-05-12 2013-12-05 Baxter Healthcare Sa Microesferas contendo oligonucleótidos, sua utilização para o fabrico de um medicamento para o tratamento de diabetes do tipo 1
JP5634009B2 (ja) * 2004-05-12 2014-12-03 バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated タンパク質を含み、そして高濃度のタンパク質で注射性能を示すミクロスフェア
EP1768651A4 (en) * 2004-07-13 2008-09-10 Altairnano Inc CERAMIC STRUCTURES FOR PREVENTING THE MISUSE OF MEDICINAL PRODUCTS
CN101010051A (zh) * 2004-07-13 2007-08-01 爱尔达纳米公司 用于控释药物的陶瓷结构
WO2006050345A1 (en) * 2004-10-29 2006-05-11 Adhesives Research, Inc. Microscopic tagging system for security identification
CN101188996B (zh) * 2005-04-27 2013-03-27 巴克斯特国际公司 表面改性的微粒及其形成和使用方法
CA2620167A1 (en) * 2005-08-23 2007-03-01 Altairnano, Inc. Highly photocatalytic phosphorus-doped anatase-tio2 composition and related manufacturing methods
US20080008843A1 (en) * 2006-03-02 2008-01-10 Fred Ratel Method for Production of Metal Oxide Coatings
US20080020175A1 (en) * 2006-03-02 2008-01-24 Fred Ratel Nanostructured Indium-Doped Iron Oxide
WO2007103812A1 (en) * 2006-03-02 2007-09-13 Altairnano, Inc. Method for low temperature production of nano-structured iron oxide coatings
US20070281031A1 (en) * 2006-06-01 2007-12-06 Guohan Yang Microparticles and methods for production thereof
CA2942128C (en) 2006-08-04 2019-11-26 Baxter Healthcare S.A. Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
EP2068845A2 (en) * 2006-10-06 2009-06-17 Baxter International Inc. Microencapsules containing surface-modified microparticles and methods of forming and using the same
WO2008043157A1 (en) 2006-10-12 2008-04-17 The University Of Queensland Compositions and methods for modulating immune responses
US20090169628A1 (en) * 2006-10-17 2009-07-02 Armark Authentication Technologies, Llc Article and method for focused delivery of therapeutic and/or diagnostic materials
US20080254258A1 (en) * 2007-04-12 2008-10-16 Altairnano, Inc. Teflon® replacements and related production methods
CN101686939B (zh) * 2007-04-17 2013-03-27 巴克斯特国际公司 用于肺部投送的核酸微粒
US9782300B2 (en) 2008-02-01 2017-10-10 Kci Licensing, Inc. Fiber-microsphere bioresorbable composite scaffold for wound healing
CN102007213B (zh) 2008-04-18 2014-08-06 巴克斯特国际公司 用于预防和/或逆转新发作的自身免疫性糖尿病的基于微球的组合物
US8323685B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
US8367427B2 (en) * 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
US20100047292A1 (en) * 2008-08-20 2010-02-25 Baxter International Inc. Methods of processing microparticles and compositions produced thereby
US8323615B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing multi-phasic dispersions
US20100078848A1 (en) * 2008-09-29 2010-04-01 Armark Authentication Technologies, Llc Spinneret and method of spinning fiber
US20100291214A1 (en) * 2008-12-23 2010-11-18 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
US20100291384A1 (en) * 2009-05-15 2010-11-18 Armark Authentication Technologies, Llc Fiber having non-uniform composition and method for making same
CN107096018A (zh) 2009-05-27 2017-08-29 西莱克塔生物科技公司 具有免疫调节剂的pH敏感释放的靶向合成纳米载体
WO2011038053A1 (en) * 2009-09-25 2011-03-31 Armark Authentication Technologies, Llc Tissue fiber scaffold and method for making
AU2011258165B2 (en) 2010-05-26 2016-11-17 Selecta Biosciences, Inc. Dose selection of adjuvanted synthetic nanocarriers
EP2399931A1 (fr) * 2010-06-22 2011-12-28 Ipsen Pharma S.A.S. Nouveaux composés octapeptidiques et leur utilisation thérapeutique
US11311610B2 (en) 2010-11-01 2022-04-26 University Of Technology Sydney Immune-modulating agents and uses therefor
WO2013019658A2 (en) 2011-07-29 2013-02-07 Selecta Biosciences, Inc. Synthetic nanocarriers comprising polymers comprising multiple immunomodulatory agents
US10695406B2 (en) 2014-05-27 2020-06-30 The University Of Queensland Modulation of cellular stress using a B-cell oxidative and/or endoplasmic reticulum stress inhibitor and a targeting agent
FR3067226B1 (fr) * 2017-06-13 2021-10-08 Rossignol Lange Element de chaussure de ski

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3567650A (en) * 1969-02-14 1971-03-02 Ncr Co Method of making microscopic capsules
US4010125A (en) * 1975-06-12 1977-03-01 Schally Andrew Victor [D-Trp6 ]-LH-RH and intermediates therefor
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
IN167096B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1985-04-04 1990-09-01 Akzo Nv
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
AU4369589A (en) * 1988-10-27 1990-05-03 Abbott Laboratories Controlled-release delivery device, method for producing device, and method of using device

Also Published As

Publication number Publication date
IN178446B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1997-05-03
SE505734C2 (sv) 1997-10-06
NL194637C (nl) 2002-10-04
FI913646L (fi) 1992-02-02
JPH05178740A (ja) 1993-07-20
HK33294A (en) 1994-04-22
ITMI911953A1 (it) 1993-01-15
DK141891D0 (da) 1991-07-31
FR2665360B1 (fr) 1995-02-10
NO912986D0 (no) 1991-07-31
LU87982A1 (fr) 1992-04-15
OA09387A (fr) 1992-09-15
BE1004772A3 (fr) 1993-01-26
IE65124B1 (en) 1995-10-04
ITMI911953A0 (it) 1991-07-15
NL194637B (nl) 2002-06-03
NO912986L (no) 1992-02-03
DE4125542A1 (de) 1992-02-06
AU8146691A (en) 1992-02-06
NL9101306A (nl) 1992-03-02
AU666808B2 (en) 1996-02-22
AT396425B (de) 1993-09-27
IE912700A1 (en) 1992-02-12
US5213812A (en) 1993-05-25
CH682715A5 (fr) 1993-11-15
PT98497A (pt) 1992-06-30
KR920003962A (ko) 1992-03-27
DK141891A (da) 1992-02-02
ATA152591A (de) 1993-01-15
GB9016885D0 (en) 1990-09-12
FI104149B (fi) 1999-11-30
FI104149B1 (fi) 1999-11-30
TNSN91067A1 (fr) 1992-10-25
ZA915565B (en) 1992-04-29
FI913646A0 (fi) 1991-07-31
GR910100330A (en) 1992-08-31
FR2665360A1 (fr) 1992-02-07
NO300158B1 (no) 1997-04-21
NZ238981A (en) 1992-11-25
SE9102249L (sv) 1992-02-02
JP2818704B2 (ja) 1998-10-30
ES2046083B1 (es) 1994-08-01
DK175756B1 (da) 2005-02-14
MA22245A1 (fr) 1992-04-01
MY107500A (en) 1995-12-30
SE9102249D0 (sv) 1991-07-26
AU5939394A (en) 1994-06-02
ES2046083A1 (es) 1994-01-16
AU649696B2 (en) 1994-06-02
IT1251788B (it) 1995-05-26
PT98497B (pt) 1997-10-31
CA2048270C (en) 1997-02-25
CA2048270A1 (en) 1992-02-02

Similar Documents

Publication Publication Date Title
GR1001512B (el) Μέ?οδος παρασκευής συν?έσεων παρατεταμένης απελευ?ερώσεως και οι συν?έσεις οι οποίες λαμβάνονται τοιουτοτρόπως.
CY1107612T1 (el) Μικροκοκκοι θειικης μορφινης, μεθοδος παρασκευης τους, και συνθεσεις περιεχουσες αυτους
NO964410L (no) Matriks-pelleter med langsom frigiving, samt fremstilling av disse
DK178583D0 (da) Praeparater med loebende frigoerelse
ES2031096T3 (es) Una composicion de implante mejorada a base de estradiol y metodo para su preparacion.
CY1105329T1 (el) Συνθεσεις και μεθοδοι για χορηγηση στο βλεννογονο
WO1999014256A8 (en) Photoresist compositions comprising polycyclic polymers with acid labile pendant groups
DE69121675D1 (de) Mikrosphäre enthaltende pharmazeutische Zusammensetzung mit kontrollierter Freigabe und Verfahren zur Herstellung
CO4910173A1 (es) Composiciones de mascara que contienen material polimerico insoluble en agua y polimeros formadores de pelicula solu- bles en agua
DK400685A (da) Praeparat med kontrolleret afgivelse
CY1106112T1 (el) Σταθepοποιημενες συνταγοποιησεις παρατεταμενης απελευθερωσης tramadol
ATE258786T1 (de) Mit apatit beschichtete feste zusammensetzung
DE58901990D1 (de) Feste pharmazeutische retardform.
MX203891B (es) Compuestos funcionales de 1, 3-dicetoamida etilenicamente insaturados, polimeros de los mismos y formulaciones de latex que contienen los mismos
NO970990D0 (no) Implanterbare formlegemer for administrering av virkestoffer til planter
ATE252375T1 (de) Bioabbaubare mikropartikeln mit verzögerter wirkstofffreisetzung
DE59909717D1 (de) Verfahren zur Herstellung von festen Dosierungsformen
NO942396L (no) Preparat med vedvarende frigiving av anti-endotelin substans
ES2194374T3 (es) Composiciones superabsorbentes y procesos para preparacion de las mismas.
MY106361A (en) Liquid softening and anti-static nonionic detergent composition with a water-soluble fraction of with soil release pet-poet copolymer.
DE59108093D1 (de) Spermicides Beschichtungsmittel
ATE206911T1 (de) Feste arzneimittelform mit polymerem material verteiltem wirkstoff
GR3018795T3 (en) Emulsion-free emulsion polymers in sustained-release pharmaceutical compositions and their production
DK1484033T3 (da) Flydende polymersammensætninger til kontrolleret frigivelse af bioaktive stoffer
GR1001558B (el) Φαρμακευτικό σκεύασμα με βάση υδροχλωρική βουφλομεδίλη υπο μορφήν δισκίων ελεγχομένης απελευ?ερώσεως & σχετική μέ?οδος παρασκευής.

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees

Effective date: 20110202